| Cat. No. | Product Name | Information | 
            
                
            	| PC-24829 | NPPB Chloride channel blocker | NPPB is a nonspecific chloride channel blocker, inhibits outward rectifying chloride currents (ORCC), suppresses glioma cell migration and invasion. | 
            
                
            	| PC-23883 | TMEM16A activator F(act) TMEM16A potentiator | TMEM16A activator F(act) (Fact) is a potent small molecule potentiator of calcium-activated chloride channel TMEM16A (ANO1) with EC50 of 6 uM. | 
            
                
            	| PC-23882 | TMEM16A activator E(act) TMEM16A activator | TMEM16A activator E(act) (Eact) is a small molecule activator of calcium-activated chloride channel TMEM16A (ANO1) with EC50 of 3 uM. | 
            
                
            	| PC-23810 | Tamsulosin TMEM16A inhibitor | Tamsulosin ((R)-(-)-YM12617 free base) is an inhibitor of α1-adrenergic receptor, also demonstrates significant antiosteoporotic effects by inhibiting calcium-activated chloride channel TMEM16A. | 
            
                
            	| PC-23489 | ClC-1 inhibitor Compound A-3 ClC-1 channel inhibitor | ClC-1 inhibitor Compound A-3 is a specific inhibitor of skeletal muscle-specific chloride ion (Cl-) channel ClC-1 with IC50 of 2.3 uM for reduction in the Cl- driven membrane conductance (Gm). | 
            
                
            	| PC-22008 | NMD670 sodium ClC-1 inhibitor | NMD670 (NMD-670) sodium salt is a potent, specific and orally bioavailable ClC-1 chloride channel inhibitor with EC50 of 1.6 uM, restores muscle function in rat models of myasthenia gravis (MG). |